奥泽沙星 T7902

Product Introduction
Bioactivity


英文名: Ozenoxacin

描述: Ozenoxacin (T-3912) 是一种非氟喹诺酮抗菌剂，对大多数从在皮肤和软组织感染中分离的微生物有活性。

体外活性: Ozenoxacin shows potent antibacterial activities against clinical isolates of Gram-positive microorganisms (MICs: 0.008 to 4 mg/L). Ozenoxacin shows good activities against strains of MRSA, MSSA, MSSE, and MRSE with 2, 3, or 4 mutations in the gyrA and grlA (parC) genes [1]. Ozenoxacin inhibits MSSA strains and S. agalactiae strains, with the rates of resistance of >10?10 and 5.3?×?10?10, respectively. The maximum MIC value for mutant strains is 8 mg/L for Ozenoxacin [2].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 1mg/ml


关键字: Inhibitor | T3912 | T 3912 | Bacterial | inhibit | Ozenoxacin

相关产品: CHIR-090 | Corilagin | Lasalocid sodium | nerolidol | Gatifloxacin hydrochloride | kaempferide | Betulinaldehyde | c-Met-IN-15 | Penicillin G benzathine | Tizoxanide

相关库: FDA-Approved Drug Library | Drug Repurposing Compound Library | Approved Drug Library | ReFRAME Related Library | Drug-induced Liver Injury (DILI) Compound Library | FDA-Approved & Pharmacopeia Drug Library | Clinical Compound Library | Anti-Bacterial Compound Library | NO PAINS Compound Library | Anti-Infection Compound Library

奥泽沙星 T7902信息由TargetMol中国为您提供，如您想了解更多关于奥泽沙星 T7902报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途